Contact Us
Drug Search Results
More Filters [+]

Pafuramidine

Alternative Names: pafuramidine, db-289, db289, db 289
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PRMT1 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Immtech
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pafuramidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Pneumonia, Pneumocystis|Lung Diseases, Interstitial|HIV Infections|Pneumocystis Infections

Phase 2: Malaria|Trypanosomiasis, African

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
C05-013

P1

Terminated

Healthy Volunteers

2009-02-01

C05-009

P3

Terminated

Pneumonia, Pneumocystis|HIV Infections|Pneumocystis Infections|Lung Diseases, Interstitial

2008-12-01

C06-015

P2

Completed

Malaria

2007-11-01

289-C-006

P2

Completed

Trypanosomiasis, African

2004-02-01

Recent News Events

Date

Type

Title

09/01/2023

PubMed

 Improved Ultrafast Power Doppler Imaging Using United Spatial-Angular Adaptive Scaling Wiener Postfilter.

02/19/2020

PubMed

 New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions